News Snapshot:
You are at: Home » Health » COVID jab maker BioNTech to build SE Asia manufacturing site. COVID jab maker BioNTech to build SE Asia manufacturing site. Health COVID jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year. Construction of the site will start this year, and it could become operational by 2023, the German company said in a statement. “With this planned mRNA production facility, we will increase our overall network capacity and expand our ability to manufacture and deliver our...
